Stay updated on GT90001+Nivolumab in Metastatic HCC Clinical Trial

Sign up to get notified when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GT90001+Nivolumab in Metastatic HCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T01:48:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Footer updates include the addition of Revision: v3.3.3 and the removal of HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T10:10:48.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added an Auto-PubMed note indicating publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2; removed the older PubMed note and revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:22:39.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The operating-status notice about government funding has been removed from the page. The clinical trial details and eligibility criteria remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T19:11:39.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Updated the site location label from 'Tainan City, Taiwan' to 'Tainan, Taiwan' in the Locations section.
    Difference
    0.1%
    Check dated 2025-11-10T17:20:54.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The study record appears updated with minor textual clarifications and a refreshed last-updated date, while the primary trial details and listed sites remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:22:42.000Z thumbnail image

Stay in the know with updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GT90001+Nivolumab in Metastatic HCC Clinical Trial page.